LD-2 disclosure · 3rd Quarter - Report
CORMEDIX INC.
via CORMEDIX INC.
Expenses$150Kself-filed spend
Client
- Name
- CORMEDIX INC.
- Description
- Biopharmaceutical company.
- Location
- New Jersey · United States of America
Registrant
- Firm
- CORMEDIX INC.
- Location
- Berkeley Heights, New Jersey, United States of America
Lobbying activities
1 issueHealth Issues
H.R. 5027, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 H.R. 5074, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 S. 4469, A bill to improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes S. 4510 - The Kidney Patient Act Issues related to patient access to infection prevention.
Lobbyistsmr CHRISTOPHER BOWLIN
TargetedSENATE · HOUSE OF REPRESENTATIVES